Stahls Illustrated Antidepressants

8519D3-5852/9780521758529

ISBN
9780521758529
作者/出版社
Stahl / Cambridge
出版年代/版次
2009 / 1

定價NT$ 950
NT$ 903
數量

重量:0.29 kg  頁數:219    裝訂:平裝  開數:20.8 x 14.8  印刷:彩色

All of the titles in the Stahl’s Illustrated Series are designed to be fun. Concepts are illustrated by full-color images that will be familiar to all readers of Stahl’s Essential Psychopharmacology, Third Edition and The Prescriber’s Guide. The texts in this user-friendly series can be supplements to figures, images, and tables. The visual learner will find that these books make psychopharmacology concepts easy to master, while the non-visual learner will enjoy a shortened text version of complex psychopharmacology concepts. Within each book, each chapter builds on previous chapters, synthesizing information from basic biology and diagnostics to building treatment plans and dealing with complications and comorbidities. Novices may want to approach Stahl’s Illustrated Series by first looking through all the graphics and gaining a feel for the visual vocabulary. Readers more familiar with these topics should find that going back and forth between images and text provides an interaction with which to vividly conceptualize complex pharmacologies. And, to help guide the reader toward more in-depth learning about particular concepts, each book ends with a Suggested Reading section.

• High profile name in psychopharmacology • New series of highly illustrated atlases that are easily carried, with each book addressing a topic in psychopharmacology • Supplemented with complementary tables and algorithms that provide clinical strategies, as well as educational objectives and questions for the reader

Contents:
1. Neurobiology of depression;
2. Selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs);
3. Norepinephrine and dopamine reuptake inhibitors (NDRIs) and selective norepinephrine reuptake inhibitors (NRIs); 4. Alpha 2 antagonists as serotonin and norepinephrine;
5. Monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs);
6. Building a treatment plan with novel treatment and augmentation options for depression;
7. Depression in women: treating symptoms throughout the life span;
8. Pharmacokinetics and algorithms to treat depression.